NCT00490503View on ClinicalTrials.gov

Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 25, 2006

Primary Completion Date

October 18, 2022

Study Completion Date

October 18, 2022

Conditions
Breast Cancer
Interventions
PROCEDURE

Magnetic Resonance Imaging (MRI)

3 Scans performed before chemotherapy, 21 days (plus or minus 3 days) after start chemotherapy (Day 1 = your first day of chemotherapy), and at end of chemotherapy/before surgery.

PROCEDURE

Magnetic Resonance Spectroscopy (MRS)

3 MRI Scans with MRS performed before chemotherapy, 21 days (plus or minus 3 days) after start chemotherapy (Day 1 = your first day of chemotherapy), and at end of chemotherapy/before surgery.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00490503 - Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter